We are looking forward to our grant review and ASCO, taking place early in June. It is always a hopeful experience to hear grant proposals debated by a panel of scientists as the Foundation tries to grasp
where we should invest your money. Because most of these dollars come from patients friends and families, and because our organization consists primarily of people living with PV, ET or MF, our focus is on what is going to have the most impact, as soon as possible. Especially in light of the uncertainty of the future of Gilead's Momeolotinib, we know first hand the eagerness to see scientific breakthroughs applied to
effective new treatments for PV, ET and MF either alone or in combination with other therapies.
We're looking forward to meeting others with MPN at some upcoming events. Please see below for updates, and check our website calendar regularly to see what's coming up in your area.